ADC Therapeutics (ADCT) Operating Expenses (2020 - 2026)
ADC Therapeutics (ADCT) posted Operating Expenses of $46.1 million for Q1 2026, down 2.74% sequentially from $47.4 million in Q3 2025, and down 10.49% YoY from $51.5 million in Q1 2025.
ADC Therapeutics (ADCT) Operating Expenses (2020 - 2026) Analysis & Trends
ADC Therapeutics has reported Operating Expenses for 7 years, with the latest figure at $46.1 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | ADC Therapeutics | 148.95 Mn | -70.15 Mn | 17.14 Mn | 44.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 44.66 Mn |
| Mar 31, 2026 | 46.10 Mn |
| Sep 30, 2025 | 47.40 Mn |
| Jun 30, 2025 | 62.99 Mn |
| Mar 31, 2025 | 51.50 Mn |
| Sep 30, 2024 | 54.03 Mn |
| Jun 30, 2024 | 46.45 Mn |
| Mar 31, 2024 | 51.67 Mn |
| Sep 30, 2023 | 50.64 Mn |
| Jun 30, 2023 | 58.93 Mn |
| Mar 31, 2023 | 70.56 Mn |
| Sep 30, 2022 | 79.44 Mn |
| Jun 30, 2022 | 86.70 Mn |
| Mar 31, 2022 | 86.86 Mn |
| Sep 30, 2021 | 70.94 Mn |
| Jun 30, 2021 | 74.24 Mn |
| Mar 31, 2021 | 70.67 Mn |
| Sep 30, 2020 | 52.43 Mn |
| Jun 30, 2020 | 44.95 Mn |
| Mar 31, 2020 | 43.89 Mn |